![Wei Fu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wei Fu
Chairman at
NOVABRIDGE BIOSCIENCES
Net worth: 74 M $ as of 30/06/2026
Profile
Mr. Wei Fu is an Independent Director at I-Mab, a Chairman at Everest Medicines Ltd., a Chief Executive Officer at Shanghai Kangshiqiao Business Consulting Co. Ltd., a Chief Executive Officer & Managing Partner at C-Bridge Capital Investment Management Ltd. and a Chief Executive Officer at Cbc Group Co. Ltd. He is on the Board of Directors at I-Mab, Ascletis Biopharmaceutical (Hangzhou) Co. Ltd., Everest Medicines (Singapore) Pte Ltd., Everest Medicines II BVI Ltd., Everest Medicines II HK Ltd., Everest Medicines II Ltd., Everonc Medicines Ltd. and Everonc Medicines, Inc. Mr. Fu was previously employed as a General Manager-Investment Department by Far East Horizon Ltd., a Head-Beijing Officer by Themes Investment Management Ltd., an Associate Director-Private Equity Department by Standard Chartered Business Consulting Beijing Co. Ltd., and a Non-Executive Director by Ascletis Pharma, Inc. He received his undergraduate degree from Nanyang Technological University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/06/2026 | 2,16,83,167 ( 6.13% ) | 68 M $ | 30/06/2026 | |
| 29/06/2026 | 71,29,885 ( 3.76% ) | 6 M $ | 30/06/2026 |
Latest news about Wei Fu
Wei Fu active positions
| Companies | Position | Start |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Chairman | 15/07/2024 |
| EVEREST MEDICINES LIMITED | Director/Board Member | 09/10/2025 |
CBC Group (Singapore) Pte. Ltd.
 CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company. | Chief Executive Officer | 01/01/2014 |
Everest Medicines (Singapore) Pte Ltd. | Director/Board Member | - |
C-Bridge Capital GP IV Ltd.
 C-Bridge Capital GP IV Ltd. Financial ConglomeratesFinance Provides investment services | Director/Board Member | - |
AffaMed Therapeutics
 AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutics for ophthalmology patients | Chairman | - |
Affamed Therapeutics (Us), Inc.
 Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company | Director/Board Member | - |
Everest Medicines II BVI Ltd. | Director/Board Member | - |
Everest Medicines II HK Ltd. | Director/Board Member | - |
| ░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Wei Fu
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Wei Fu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
76
1st degree connections
21
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 21 |
|---|---|
Nanyang Technological University
 Nanyang Technological University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Themes Investment Management Ltd.
 Themes Investment Management Ltd. Investment ManagersFinance Themes Investment Management invests in companies located in China. It provides financing for buyout and special situation transactions. It also makes co-investment. | Finance |
Far East Horizon Ltd.
 Far East Horizon Ltd. Finance/Rental/LeasingFinance Provides financial and advisory & industrial operation services | Finance |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Manufactures therapeutic products | Health Technology |
Hugel, Inc.
 Hugel, Inc. BiotechnologyHealth Technology Manufactures and supplies toxin products, cosmetics, medical devices and pharmaceuticals | Health Technology |
CBC Group (Singapore) Pte. Ltd.
CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company. | Finance |
Everest Medicines Ltd.
 Everest Medicines Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies to address critical unmet medical needs | Health Technology |
Ascletis Pharma, Inc.
 Ascletis Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology firm which develops drugs for HIV, HCV and HBV diseases | Health Technology |
CBC Group Co., Ltd. | |
AffaMed Therapeutics
AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutics for ophthalmology patients | Health Technology |
I-Mab
 I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
C-Bridge Capital Investment Management Ltd. | |
Standard Chartered Business Consulting Beijing Co. Ltd. | |
Everest Medicines II Ltd.
 Everest Medicines II Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Everest Medicines II HK Ltd. | |
Everest Medicines (Singapore) Pte Ltd. | |
Everonc Medicines Ltd. | |
Everonc Medicines, Inc. | |
Everest Medicines II BVI Ltd. | |
Affamed Therapeutics (Us), Inc.
Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
C-Bridge Capital GP IV Ltd.
C-Bridge Capital GP IV Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
- Stock Market
- Insiders
- Wei Fu
